Skip to main content

Table 1 General information of the patients

From: Efficacy and safety analysis of dexamethasone-lipiodol emulsion in prevention of post-embolization syndrome after TACE: a retrospective analysis

 

Group

Chi-square test (P value)

TACE (N = 133)

TACE + Dexamethasone (N = 122)

Pearson chi-square

Fisher’s exact test

Gender

 Female

  Count (%)

68 (51.1%)

52 (42.6%)

0.174

0.209

 Male

  Count (%)

65 (48.9%)

70 (57.4%)

  

Child–Pugh classification of liver function

 A

  Count (%)

95 (71.4%)

85 (69.7%)

0.758

0.784

 B

  Count (%)

38 (28.6%)

37 (30.3%)

  

Etiology of cirrhosis

 Hepatitis B

  Count (%)

120 (90.2%)

111 (91.0%)

0.836

1.000

 Hepatitis C

  Count (%)

13 (9.8%)

11 (9.0%)

  

BCLC staging

 A

  Count (%)

14 (10.5%)

12 (9.8%)

0.682

 

 B

  Count (%)

80 (60.2%)

68 (55.7%)

  

 C

  Count (%)

39 (29.3%)

42 (34.4%)

  

History of vomiting

 No

  Count (%)

108 (81.2%)

95 (77.9%)

0.509

0.537

 Yes

  Count (%)

25 (18.8%)

27 (22.1%)

  

Motion sickness

 No

  Count (%)

100 (75.2%)

99 (81.1%)

0.251

0.290

 Yes

  Count (%)

33 (24.8%)

23 (18.9%)

  

Smoking history

 No

  Count (%)

105 (78.9%)

100 (82.0%)

0.544

0.636

 Yes

  Count (%)

28 (21.1%)

22 (18.0%)

  

Alcohol history

 No

  Count (%)

110 (82.7%)

103 (84.4%)

0.712

0.738

 Yes

  Count (%)

23 (17.3%)

19 (15.6%)

  

History of analgesics

 No

  Count (%)

93 (69.9%)

90 (73.8%)

0.496

0.578

 Yes

  Count (%)

40 (30.1%)

32 (26.2%)

  

Preoperative fasting

 No

  Count (%)

65 (48.9%)

69 (56.6%)

0.220

0.259

 Yes

  Count (%)

68 (51.1%)

53 (43.4%)